Advanced search
Publication Cover
Expert Review of Ophthalmology Volume 7, 2012 - Issue 5
Submit an article Journal homepage
73
Views
2
CrossRef citations to date
0
Altmetric
Review

Idiopathic intracranial hypertension

Katrina A Mears Department of Ophthalmology, Kresge Eye Institute, Wayne State University, 4717 St Antoine, Detroit, MI 48201, USA. [email protected]; Department of Ophthalmology, Kresge Eye Institute, Wayne State University, 4717 St Antoine, Detroit, MI 48201, USA. [email protected]
&
Gregory P Van Stavern Departments of Ophthalmology and Visual Sciences and Neurology, Washington University School of Medicine, 660 S. Euclid Ave., St Louis, MO 63110, USA; Departments of Ophthalmology and Visual Sciences and Neurology, Washington University School of Medicine, 660 S. Euclid Ave., St Louis, MO 63110, USA
Pages 487-498 | Published online: 09 Jan 2014

References

  • Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch. Neurol. 45(8), 875–877 (1988).
  • Friesner D, Rosenman R, Lobb BM, Tanne E. Idiopathic intracranial hypertension in the USA: the role of obesity in establishing prevalence and healthcare costs. Obes. Rev. 12(5), e372–e380 (2011).
  • Bruce BB, Kedar S, Van Stavern GP et al. Idiopathic intracranial hypertension in men. Neurology 72(4), 304–309 (2009).
  • Asensio-Sánchez VM, Merino-Angulo J, Martínez-Calvo S, Calvo MJ, Rodríguez R. Epidemiology of pseudotumor cerebri. Arch. Soc. Esp. Oftalmol. 82(4), 219–221 (2007).
  • Carta A, Bertuzzi F, Cologno D, Giorgi C, Montanari E, Tedesco S. Idiopathic intracranial hypertension (pseudotumor cerebri): descriptive epidemiology, clinical features, and visual outcome in Parma, Italy, 1990 to 1999. Eur. J. Ophthalmol. 14(1), 48–54 (2004).
  • Radhakrishnan K, Thacker AK, Bohlaga NH, Maloo JC, Gerryo SE. Epidemiology of idiopathic intracranial hypertension: a prospective and case–control study. J. Neurol. Sci. 116(1), 18–28 (1993).
  • Rangwala LM, Liu GT. Pediatric idiopathic intracranial hypertension. Surv. Ophthalmol. 52(6), 597–617 (2007).
  • Genizi J, Lahat E, Zelnik N, Mahajnah M, Ravid S, Shahar E. Childhood-onset idiopathic intracranial hypertension: relation of sex and obesity. Pediatr. Neurol. 36(4), 247–249 (2007).
  • Scott IU, Siatkowski RM, Eneyni M, Brodsky MC, Lam BL. Idiopathic intracranial hypertension in children and adolescents. Am. J. Ophthalmol. 124(2), 253–255 (1997).
  • Smith JL. Whence pseudotumor cerebri? J. Clin. Neuroophthalmol. 5(1), 55–56 (1985).
  • Digre KB, Corbett JJ. Idiopathic intracranial hypertension (pseudotumor cerebri): a reappraisal. Neurologist 7, 2–67 (2001).
  • Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 59(10), 1492–1495 (2002).
  • Sinclair AJ, Burdon MA, Nightingale PG et al. Rating papilloedema: an evaluation of the Frisén classification in idiopathic intracranial hypertension. J. Neurol. 259(7), 1406–1412 (2012).
  • Farb RI, Vanek I, Scott JN et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 60(9), 1418–1424 (2003).
  • Agid R, Farb RI, Willinsky RA, Mikulis DJ, Tomlinson G. Idiopathic intracranial hypertension: the validity of cross-sectional neuroimaging signs. Neuroradiology 48(8), 521–527 (2006).
  • Daniels AB, Liu GT, Volpe NJ et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am. J. Ophthalmol. 143(4), 635–641 (2007).
  • Rowe FJ, Sarkies NJ. The relationship between obesity and idiopathic intracranial hypertension. Int. J. Obes. Relat. Metab. Disord. 23(1), 54–59 (1999).
  • Sugerman HJ, DeMaria EJ, Felton WL 3rd, Nakatsuka M, Sismanis A. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology 49(2), 507–511 (1997).
  • Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144(6), 2195–2200 (2003).
  • Dhungana S, Sharrack B, Woodroofe N. Cytokines and chemokines in idiopathic intracranial hypertension. Headache 49(2), 282–285 (2009).
  • Perrier S, Caldefie-Chézet F, Vasson MP. IL-1 family in breast cancer: potential interplay with leptin and other adipocytokines. FEBS Lett. 583(2), 259–265 (2009).
  • Lampl Y, Eshel Y, Kessler A et al. Serum leptin level in women with idiopathic intracranial hypertension. J. Neurol. Neurosurg. Psychiatr. 72(5), 642–643 (2002).
  • Ball AK, Sinclair AJ, Curnow SJ et al. Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance? Clin. Endocrinol. (Oxf.) 70(6), 863–869 (2009).
  • Inui A, Asakawa A, Bowers CY et al. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J. 18(3), 439–456 (2004).
  • Soriano-Guillén L, Barrios V, Campos-Barros A, Argente J. Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J. Pediatr. 144(1), 36–42 (2004).
  • Subramanian PS, Goldenberg-Cohen N, Shukla S, Cheskin LJ, Miller NR. Plasma ghrelin levels are normal in obese patients with idiopathic intracranial hypertension (pseudotumor cerebri). Am. J. Ophthalmol. 138(1), 109–113 (2004)
  • Ball AK, Sinclair AJ, Curnow SJ et al. Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance? Clin. Endocrinol. (Oxf.) 70(6), 863–869 (2009).
  • Rodahl K, Moore T. The vitamin A content and toxicity of bear and seal liver. Biochem. J. 37(2), 166–168 (1943).
  • Jacobson DM, Berg R, Wall M, Digre KB, Corbett JJ, Ellefson RD. Serum vitamin A concentration is elevated in idiopathic intracranial hypertension. Neurology 53(5), 1114–1118 (1999).
  • Smith FR, Goodman DS. Vitamin A transport in human vitamin A toxicity. N. Engl. J. Med. 294(15), 805–808 (1976).
  • Herbert J, Wilcox JN, Pham KT et al. Transthyretin: a choroid plexus-specific transport protein in human brain. The 1986 S. Weir Mitchell award. Neurology 36(7), 900–911 (1986).
  • Tabassi A, Salmasi AH, Jalali M. Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension. Neurology 64(11), 1893–1896 (2005).
  • Warner JE, Larson AJ, Bhosale P et al. Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension. J. Neuroophthalmol. 27(4), 258–262 (2007).
  • Johnston I, Hawke S, Halmagyi M, Teo C. The pseudotumor syndrome. Disorders of cerebrospinal fluid circulation causing intracranial hypertension without ventriculomegaly. Arch. Neurol. 48(7), 740–747 (1991).
  • King JO, Mitchell PJ, Thomson KR, Tress BM. Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology 58(1), 26–30 (2002).
  • Bono F, Giliberto C, Mastrandrea C et al. Transverse sinus stenoses persist after normalization of the CSF pressure in IIH. Neurology 65(7), 1090–1093 (2005).
  • De Simone R, Ranieri A, Cardillo G, Bonavita V. High prevalence of bilateral transverse sinus stenosis-associated IIHWOP in unresponsive chronic headache sufferers: pathogenetic implications in primary headache progression. Cephalalgia 31(6), 763–765 (2011).
  • Santos-Lasaosa S, Martínez-Martínez M, López del Val J, Pérez-Lázaro C. [Incidence of venous system disease in pseudotumor cerebri]. Neurologia. 24(7), 462–464 (2009).
  • Stevens SA, Stimpson J, Lakin WD, Thakore NJ, Penar PL. A model for idiopathic intracranial hypertension and associated pathological ICP wave-forms. IEEE Trans. Biomed. Eng. 55(2 Pt 1), 388–398 (2008).
  • Bicakci K, Bicakci S, Aksungur E. Perfusion and diffusion magnetic resonance imaging in idiopathic intracranial hypertension. Acta Neurol. Scand. 114(3), 193–197 (2006).
  • Badaut J, Lasbennes F, Magistretti PJ, Regli L. Aquaporins in brain: distribution, physiology, and pathophysiology. J. Cereb. Blood Flow Metab. 22(4), 367–378 (2002).
  • Manley GT, Fujimura M, Ma T et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat. Med. 6(2), 159–163 (2000).
  • Kerty E, Heuser K, Indahl UG et al. Is the brain water channel aquaporin-4 a pathogenetic factor in idiopathic intracranial hypertension? Results from a combined clinical and genetic study in a Norwegian cohort. Acta Ophthalmol. doi:10.1111/j.1755-3768.2011.02231.x (2011) (Epub ahead of print).
  • Kesler A, Kliper E, Assayag EB et al. Thrombophilic factors in idiopathic intracranial hypertension: a report of 51 patients and a meta-analysis. Blood Coagul. Fibrinolysis 21(4), 328–333 (2010).
  • Finsterer J, Kuntscher D, Brunner S, Krugluger W. Pseudotumor cerebri from sinus venous thrombosis, associated with polycystic ovary syndrome and hereditary hypercoagulability. Gynecol. Endocrinol. 23(3), 179–182 (2007).
  • Biousse V. Coagulation abnormalities and their neuro-ophthalmologic manifestations. Curr. Opin. Ophthalmol. 10(6), 382–393 (1999).
  • Miller NL, Walsh FB, Newman NJ, Biousse V, Kerrison JB. Walsh and Hoyts clinical neuro-ophthalmology: the essentials. Lippincott Williams and Wilkins, Philadelphia, PA, USA, 122–146 (2007)
  • Hacifazlioglu Eldes N, Yilmaz Y. Pseudotumour cerebri in children: Etiological, clinical features and treatment modalities. Eur. J. Paediatr. Neurol. 16(4), 349–355 (2012).
  • Fraser JA, Bruce BB, Rucker J et al. Risk factors for idiopathic intracranial hypertension in men: a case–control study. J. Neurol. Sci. 290(1–2), 86–89 (2010).
  • Hughes TA, Smith PE, McQueen IN, Scanlon MF. Leydig cell tumour of the testicle associated with benign intracranial hypertension. J. Neurol. 241(3), 177–178 (1994).
  • Toscano V, Sancesario G, Bianchi P, Cicardi C, Casilli D, Giacomini P. Cerebrospinal fluid estrone in pseudotumor cerebri: a change in cerebral steroid hormone metabolism? J. Endocrinol. Invest. 14(2), 81–86 (1991).
  • Wall M. Idiopathic intracranial hypertension. Neurol. Clin. 28(3), 593–617 (2010).
  • Wall M. The headache profile of idiopathic intracranial hypertension. Cephalalgia 10(6), 331–335 (1990).
  • Sadun AA, Currie JN, Lessell S. Transient visual obscurations with elevated optic discs. Ann. Neurol. 16(4), 489–494 (1984).
  • Baheti NN, Nair M, Thomas SV. Long-term visual outcome in idiopathic intracranial hypertension. Ann. Indian Acad. Neurol. 14(1), 19–22 (2011).
  • Wall M, George D. Visual loss in pseudotumor cerebri. Incidence and defects related to visual field strategy. Arch. Neurol. 44(2), 170–175 (1987).
  • Farb RI, Vanek I, Scott JN et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 60(9), 1418–1424 (2003).
  • Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 114(Pt 1A), 155–180 (1991).
  • Cushing H. Strangulation of the nerve abducentes by the lateral branches of the basilar artery. Brain 33, 204–235 (1910)
  • Sinclair AJ, Burdon MA, Nightingale PG et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ 341, c2701 (2010).
  • Johnson LN, Krohel GB, Madsen RW, March GA Jr. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 105(12), 2313–2317 (1998).
  • Newborg B. Pseudotumor cerebri treated by rice reduction diet. Arch. Intern. Med. 133(5), 802–807 (1974).
  • Kupersmith MJ, Gamell L, Turbin R, Peck V, Spiegel P, Wall M. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 50(4), 1094–1098 (1998).
  • Lueck C, McIlwaine G. Interventions for idiopathic intracranial hypertension. Cochrane Database Syst. Rev. 3, CD003434 (2005).
  • Ball AK, Howman A, Wheatley K et al. A randomised controlled trial of treatment for idiopathic intracranial hypertension. J. Neurol. 258(5), 874–881 (2011).
  • Lee AG, Pless M, Falardeau J, Capozzoli T, Wall M, Kardon RH. The use of acetazolamide in idiopathic intracranial hypertension during pregnancy. Am. J. Ophthalmol. 139(5), 855–859 (2005).
  • Jacopin-Bruneau L, Gommier B, Pierre F, Boog G. [Idiopathic intracranial hypertension and pregnancy. A report of two cases]. J. Gynecol. Obstet. Biol. Reprod. (Paris). 39(3), 246–250 (2010).
  • Giuliari GP, Banda RM, Vann VR, Gonzalez VH, McMillin RB. Closed-angle glaucoma after topiramate therapy for migraine in a patient with undiagnosed pseudotumor cerebri. Can. J. Ophthalmol. 43(3), 371 (2008).
  • Celebisoy N, Gökçay F, Sirin H, Akyürekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol. Scand. 116(5), 322–327 (2007).
  • Finsterer J, Földy D, Fertl E. Topiramate resolves headache from pseudotumor cerebri. J. Pain Symptom Manage. 32(5), 401–402 (2006).
  • Palacio E, Rodero L, Pascual J. Topiramate-responsive headache due to idiopathic intracranial hypertension in Behçet syndrome. Headache 44(5), 436–437 (2004).
  • Deftereos SN, Panagopoulos G, Georgonikou D, Karageorgiou CE, Karageorgiou E, Piadites G. Treatment of idiopathic intracranial hypertension: Is there a place for octreotide? Cephalalgia 31(16), 1679–1680 (2011).
  • Sinclair AJ, Walker EA, Burdon MA et al. Cerebrospinal fluid corticosteroid levels and cortisol metabolism in patients with idiopathic intracranial hypertension: a link between 11beta-HSD1 and intracranial pressure regulation? J. Clin. Endocrinol. Metab. 95(12), 5348–5356 (2010).
  • Liu GT, Kay MD, Bienfang DC, Schatz NJ. Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease. Am. J. Ophthalmol. 117(3), 352–357 (1994).
  • Sinclair AJ, Kuruvath S, Sen D, Nightingale PG, Burdon MA, Flint G. Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia 31(16), 1627–1633 (2011).
  • Brazis PW. Clinical review: the surgical treatment of idiopathic pseudotumour cerebri (idiopathic intracranial hypertension). Cephalalgia 28(12), 1361–1373 (2008).
  • Rosenberg ML, Corbett JJ, Smith C et al. Cerebrospinal fluid diversion procedures in pseudotumor cerebri. Neurology 43(6), 1071–1072 (1993).
  • Tarnaris A, Toma AK, Watkins LD, Kitchen ND. Is there a difference in outcomes of patients with idiopathic intracranial hypertension with the choice of cerebrospinal fluid diversion site: a single centre experience. Clin. Neurol. Neurosurg. 113(6), 477–479 (2011).
  • Abubaker K, Ali Z, Raza K, Bolger C, Rawluk D, O’Brien D. Idiopathic intracranial hypertension: lumboperitoneal shunts versus ventriculoperitoneal shunts – case series and literature review. Br. J. Neurosurg. 25(1), 94–99 (2011).
  • Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology 46(6), 1524–1530 (1996).
  • Woodworth GF, McGirt MJ, Elfert P, Sciubba DM, Rigamonti D. Frameless stereotactic ventricular shunt placement for idiopathic intracranial hypertension. Stereotact. Funct. Neurosurg. 83(1), 12–16 (2005).
  • Alsuhaibani AH, Carter KD, Nerad JA, Lee AG. Effect of optic nerve sheath fenestration on papilledema of the operated and the contralateral nonoperated eyes in idiopathic intracranial hypertension. Ophthalmology 118(2), 412–414 (2011).
  • Plotnik JL, Kosmorsky GS. Operative complications of optic nerve sheath decompression. Ophthalmology 100(5), 683–690 (1993).
  • Ahmed RM, Wilkinson M, Parker GD et al. Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR. Am. J. Neuroradiol. 32(8), 1408–1414 (2011).
  • Skau M, Milea D, Sander B, Wegener M, Jensen R. OCT for optic disc evaluation in idiopathic intracranial hypertension. Graefes Arch. Clin. Exp. Ophthalmol. 249(5), 723–730 (2011).
  • Alessi G, Levrier O, Conrath J et al. Optical coherence tomography in following up papilledema in idiopathic intracranial hypertension treated with lateral sinus stent placement. J. Fr. Ophtalmol. 33(9), 637–648 (2010).
  • Rebolleda G, Muñoz-Negrete FJ. Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography. Invest. Ophthalmol. Vis. Sci. 50(11), 5197–5200 (2009).
  • El-Dairi MA, Holgado S, O’Donnell T, Buckley EG, Asrani S, Freedman SF. Optical coherence tomography as a tool for monitoring pediatric pseudotumor cerebri. J. AAPOS 11(6), 564–570 (2007).
  • Waisbourd M, Leibovitch I, Goldenberg D, Kesler A. OCT assessment of morphological changes of the optic nerve head and macula in idiopathic intracranial hypertension. Clin. Neurol. Neurosurg. 113(10), 839–843 (2011).
  • Radvany MG, Ehtiati T, Huang J, Mahesh M, Gailloud P. Aortic arch injection with C-arm cone beam CT for radiosurgery treatment planning of cerebral arteriovenous malformations: technical note. J. Neurointerv. Surg. 4(5), e28 (2011).
  • Hunter G, Voll C, Rajput M. Utility of transcranial doppler in idiopathic intracranial hypertension. Can. J. Neurol. Sci. 37(2), 235–239 (2010).
  • Sander K, Poppert H, Etgen T, Hemmer B, Sander D. Dynamics of intracranial venous flow patterns in patients with idiopathic intracranial hypertension. Eur. Neurol. 66(6), 334–338 (2011).
  • Frisén L. Swelling of the optic nerve head: a staging scheme. J. Neurol. Neurosurg. Psychiatr. 45(1), 13–18 (1982).
  • Corbett JJ, Thompson HS. The rational management of idiopathic intracranial hypertension. Arch. Neurol. 46(10), 1049–1051 (1989).
  • Mowl AD, Grogg JA, Klein J. Secondary pseudotumour cerebri in a patient undergoing sexual reassignment therapy. Clin. Exp. Optom. 92(5), 449–453 (2009).
  • Friedman DI. Pseudotumor cerebri presenting as headache. Expert Rev. Neurother. 8(3), 397–407 (2008).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.